| 09-Oct-2015 | S | SMS Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 09, 2015, has taken the following decisions:
1. Considered and approved the Sub division of the equity shares of Rs. 10/- each of the Company into 10 (ten) shares of Rs. 1/- each commonly known as 'Stock Split' and recommended the matter to the Members of the Company for their approval by way of postal ballot.
SUB. :- Sub Division of equity shares of SMS Pharmaceuticals Limited (Scrip Code 532815)
Trading Members of the Exchange are hereby informed that SMS Pharmaceuticals Limited has fixed Record Date for the purpose of sub division of equity shares of the company.
DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT
COMPANY NAME & CODE
SMS Pharmaceuticals Limited
(532815)
RECORD DATE
18/12/2015
PURPOSE
Sub Division of existing equity shares from every ONE equity share of Rs.10/- each into TEN equity shares of Re.1/- each.
SUB-DIVIDED PAID-UP VALUE
Re.1/-
SUB-DIVIDED PAID-UP VALUE W.E.F.
17/12/2015 DR- 179/2015- 2016
Note :-
i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Re. 1/- paid up w.e.f. 17/12/2015.
ii. ISIN No. INE812G01017 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 17/12/2015.
iii. The new ISIN Number for Re.1/- paid up will be informed to the market by a separate notice.
(As Per BSE Notice Dated on 08.12.2015) | 18-Dec-2015 | |
| 25-May-2023 | D | Recommended the Dividend of Re.0.30 Paise (30%) per equity share of face value of Rs.1/-each for the financial year 2022-23. | 22-Sep-2023 | |
| 30-May-2022 | D | Recommended the Dividend of 30% per equity share of face value of Rs. 1/-each for the financial year 2021-22
| 22-Sep-2022 | |
| 28-May-2021 | D | SMS Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2021, inter alia, has considered and approved the following:
- Declaration of Dividend for the year 2020-21 @ Re. 0.30/- (30%) per equity share of Re. 1/- each.
| 22-Sep-2021 | |
| 18-Mar-2020 | D | Pursuant to Regulation 30 and other applicable provisions of SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on today 18th March, 2020 have declared interim dividend of Re. 0.25 paise per Equity share i.e @ 25% per fully paid up equity share of Rs.1.00 each for the financial year 2019-20.
Further, pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015 the Company has fixed the 'March 26th 2020 as 'Record Date' for determining the eligibility of the Shareholders. The Dividend amount will be paid on or after 28th March, 2020. | 26-Mar-2020 | |
| 27-May-2019 | D | SMS Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 27, 2019, inter alia, has recommended a dividend of Re. 0.25 (25 %) per equity share of Re. 1/- (Rupee One) each (face value), for the financial year ended March 31, 2019. The dividend will be paid subject to the approval of the shareholders at the ensuing Annual General Meeting. | 19-Sep-2019 | |
| 26-May-2018 | D | SMS Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 26, 2018, inter alia, has recommended a dividend of Re. 0.25 (25%) per equity share of Re.1/- (Rupee One) each (face value); for the financial year ended March 31, 2018. The dividend will be paid subject to the approval of the shareholders at the ensuing Annual General Meeting. | 11-Sep-2018 | |
| 30-May-2017 | D | SMS Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2017, inter alia, has recommended a dividend of Rs. 0.20/- (i.e. 20%) per equity share of Rs. 1/- (Rupee One) each (face value), for the financial year ended March 31, 2017. The dividend will be paid subject to the approval of the shareholders at the ensuing Annual General Meeting. | 20-Sep-2017 | |
| 14-May-2016 | D | SMS Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2016, inter alia, has recommended dividend a final dividend of Rs. 0.20/- (i.e. 20%) per equity share of Rs. 1/- face value, aggregating of Rs. 1,69,30,406/- which shall be paid within 30 days after the conclusion of the Annual General meeting, subject to the approval of the shareholders of the Company. | 22-Sep-2016 | |
| 31-May-2015 | D | SMS Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2015, inter alia, has taken the following decisions:
1. Recommended dividend of Rs. 2.00 (Rupee Two Only) per equity share of Rs. 10/- each on the paid up share capital of the company for the year 2014-15. | 22-Sep-2015 | |
| 30-May-2014 | D | SMS Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2014, inter alia, has recommended dividend of Rs. 2.00 (Rupee Two Only) per equity share of Rs. 10/- each on the paid up share capital of the Company for the year 2013-14. | 23-Sep-2014 | |
| 30-May-2013 | D | SMS Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2013, inter alia, has recommended dividend of Rs. 2.00 (Rupee Two Only) per equity share of Rs. 10/- each on the paid up share capital of the Company for the year 2012-13. | 23-Sep-2013 | |
| 05-Aug-2011 | D | Sms Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on August 05, 2011, inter alia, has taken the following decisions : Recommended dividend of Rs. 1.50 (Rupee One and Fifty Paisa Only) per equity share of Rs. 10/- each on the paid up share capital of the company for the year 2010-11. | 22-Sep-2011 | |
| 27-Aug-2010 | D | SMS Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 27, 2010, inter alia, has recommended dividend of Re. 1/- (Rupee One Only) per equity share of Rs. 10/- each on the paid up share capital of the company for the year 2009-10. | 23-Sep-2010 | |
| 10-Aug-2009 | D | SMS Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 10, 2009, inter alia, has recommended dividend of Rs 2/- per equity share of Rs 10/- each on the paid up share capital of the Company for the year 2008-09. | 23-Sep-2009 | |
| 01-Dec-2008 | D | SMS Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 29, 2008, inter alia, has taken the following decisions:
Recommended 20% dividend on the paid up share capital of the Company for the year 2007-08. | 23-Dec-2008 | |
| 28-Aug-2007 | D | SMS Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 27, 2007, inter alia, has recommended 20% dividend on the paid up share capital of the Company for the year 2006-07. | 21-Sep-2007 | |
| 01-Apr-2024 | BC | TVT Infracon LLP | 27-Mar-2024 | |
| 01-Apr-2024 | BC | Hima Bindu Potluri | 27-Mar-2024 | |
| 01-Apr-2024 | BC | TVT Infracon LLP | 27-Mar-2024 | |
| 01-Apr-2024 | BC | Neelima Potluru | 27-Mar-2024 | |
| 01-Apr-2024 | BC | P Seeta Rama Brahmam | 27-Mar-2024 | |